Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by JDavenporton Feb 28, 2022 8:11pm
198 Views
Post# 34469561

Questions for cmonreally24 and his buds

Questions for cmonreally24 and his budsMy first question for cmonreally24 is about a logic failure. cmonreally24 says that "The number of shareholders that have lost money due to  JD is probably why the new CEO canned JD, stopped paying him 18 months ago, thanked him for his services,  while he continued to write "for them"."

Everything I post is either available in the public domain or is an opinion formed from public information. All facts are presented as such and all opinions use words like "may," "could," "I think that...," etc., etc.

So if my posts, based on public information with links, are so influential and have kept so many people in the stock, then wouldn't that make me an investor relations asset for a public company? 

Don't worry, cmonreally24, beenthere makes the same mistake on a regular basis.

Secondly, Bioasis did not stop paying me 18 months ago. I was paid in September and October, and occasionally, in previous months, but the payments still left the company far behind in its payments to me. So that's a falsehood, cmonreally24. 

DrDR thanked me in April 2019 for my "historical" service to the company and in February 2020 for a document I created for her. Otherwise, no thanks that I can recall. 

Also, I have described the periods during which I wrote both for and about Bioasis. There is a difference.

That first sentence is full of falsehoods, cmonreally24.

So how about me joining you? I don't get any support on here. How about I switch sides? What would it be like if I join you and your buddies beenthere, Aarcor, Finallythe rock and others?

I know stuff about brokers and other shareholders, things that are not covered by my NDAs. I can make an easy dozen deep posts about why Bioasis might fail in ways far greater than it has so far. I know enough science to give Bioasis a big bunch of heartburn.

What about the two AWFUL deals signed by the current chair?

I can post stuff like that every day for months.

Would you, cmonreally24, be my buddy if I set about to destroy Bioasis? I mean, I could do a far better job of destruction than you and your bonehead buddies could ever dream of doing. 

When would you like me to start?

jd
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse